High Tech Pharm Co., Ltd. (KOSDAQ:106190)
10,310
+10 (0.10%)
At close: Sep 11, 2026
High Tech Pharm Revenue
High Tech Pharm had revenue of 23.38B KRW in the quarter ending June 30, 2026, with 1.56% growth. This brings the company's revenue in the last twelve months to 69.41B, down -7.02% year-over-year. In the year 2025, High Tech Pharm had annual revenue of 70.18B, down -9.46%.
Revenue (ttm)
69.41B
Revenue Growth
-7.02%
P/S Ratio
1.58
Revenue / Employee
1.07B
Employees
65
Market Cap
109.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.18B | -7.33B | -9.46% |
| Dec 31, 2024 | 77.51B | 740.98M | 0.97% |
| Dec 31, 2023 | 76.77B | -26.18B | -25.43% |
| Dec 31, 2022 | 102.95B | 29.66B | 40.47% |
| Dec 31, 2021 | 73.29B | -1.17B | -1.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 345.08B |
| H.PIO | 269.63B |
| DongKoo Bio & Pharma | 241.43B |
| Kyung Dong Pharmaceutical | 201.12B |
| HYUNDAI BIOLAND | 140.70B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.72B |
| OPTUS Pharmaceutical | 94.47B |
| KOREA PHARMA | 93.94B |